Docosahexaenoic Acid Signaling Modulates Cell Survival in Experimental Ischemic Stroke Penumbra and Initiates Long-Term Repair in Young and Aged Rats

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Eady, Tiffany N ^a   Belayev, Ludmila ^a   Khoutorova, Larissa ^a   Atkins, Kristal D ^a   Zhang, Changde ^a   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; NEUROPROTECTIN D1; NEUROPROTECTIVE AGENT; PROTEIN KINASE B; S6 KINASE; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL COUNT; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BEHAVIOR; BRAIN ISCHEMIA; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; STROKE;

ANIMALIA; RATTUS;

EID: 84868104097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046151     Document Type: Article

References (36)

1. Towfighi A, Saver JL, (2011) Stroke decline from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke 8: 2351-55.
2. Aurel PW, Stanley-Thomas C, Zaal K, Christof K, Lary CW, (2007) The Response of the Aged Brain to Stroke: Too Much, Too Soon? Curr Neurovasc Res 4: 216-227.
3. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, et al. (2006) 1,026 Experimental treatments in acute stroke. Ann Neurol 59: 467-477.
4. Lo EH, (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14: 497-500.
5. Belayev L (2012) Overcoming barriers to translation from experimental stroke models. In: Lapchak, Zhang editors. Stroke targets to clinical trials. Springer. pp. 471-492.
6. Muralikrishna A, Hatcher JF, (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40: 376-387.
7. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, et al. (2003) Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression. J Biol Chem 278: 43807-43817.
8. Belayev L, Lu Y, Bazan NG (2012) Brain ischemia and reperfusion: cellular and molecular mechanisms in stroke injury. In: Brady, Albers, Price, Siegel, editors. Basic Neurochemistry. Elsevier. pp. 621-642.
9. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG, (2004) Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101: 8491-8496.
10. Bazan NG, (2005) Neuroprotectin D1 (NPD1): A DHA-Derived Mediator that Protects Brain and Retina Against Cell Injury-Induced Oxidative Stress. Brain Pathol 15: 159-166.
11. Niemoller TD, Stark DT, Bazan NG, (2009) Omega-3 fatty acid docosahexaenoic acid is the precursor of neuroprotectin D1 in the nervous system. World Rev Nutr Diet 99: 46-54.
12. Bazan NG, (2003) Synaptic lipid signaling. J Lipid Res 44: 2221-2233.
13. Bazan NG, (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29: 263-271.
14. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, et al. (2005) Docosahexaenoic Acid Complexed to Albumin Elicits High-Grade Ischemic Neuroprotection. Stroke 36: 118-123.
15. Belayev L, Khoutorova L, Atkins KD, Bazan NG, (2009) Robust Docosahexaenoic Acid-Mediated Neuroprotection in a Rat Model of Transient, Focal Cerebral Ischemia. Stroke 40: 3121-3126.
16. Belayev L, Khoutorova L, Atkins K, Eady T, Hong S, et al. (2011) Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke. Transl Stroke Res 2: 33-41.
17. Akbar M, Calderon F, Wen Z, Kim HY, (2005) Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 102: 10858-10863.
18. Guo M, Stockert L, Akbar M, Kim HY, (2007) Neuronal Specific Increase of Phosphatidylserine by Docosahexaenoic Acid. J Mol Neurosci 33: 67-73.
19. Pignataro G, Capone D, Polichetti G, Vinciguerra A, Gentile A, et al. (2011) Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options. Curr Opin Pharmacol 4: 378-94.
20. Wullschleger S, Loewith R, Hall MN, (2006) TOR Signaling in Growth and Metabolism. Cell 124: 471-484.
21. Manning BD, (2004) Balancing Akt with S6K. J Cell Biol 167: 399-403.
22. Gao X, Zhang H, Steinberg G, Zhao H, (2010) The Akt Pathway Is Involved in Rapid Ischemic Tolerance in Focal Ischemia in Rats. Transl Stroke Res 1: 202-209.
23. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-51.
24. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex. Science 307: 1098-1101.
25. Zhao H, Sapolsky R, Steinberg G, (2006) Phosphoinositide-3-kinase/Akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34: 249-269.
26. Kim HY, (2007) Novel Metabolism of Docosahexaenoic Acid in Neural Cells. J Biol Chem 282: 18661-18665.
27. Uauy R, Dangour AD, (2006) Nutrition in Brain Development and Aging: Role of Essential Fatty Acids. Nutr Rev 64: S24-S33.
28. Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM, (2010) Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 6: 256-265.
29. DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL, (2008) Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging 29: 753-764.
30. Liu F, Yuan R, Benashski SE, McCullough LD, (2009) Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 29: 792-802.
31. Calandria JM, Marcheselli VL, Mukherjee PK, Uddin J, Winkler JW, et al. (2009) Selective Survival Rescue in 15-Lipoxygenase-1-deficient Retinal Pigment Epithelial Cells by the Novel Docosahexaenoic Acid-derived Mediator, Neuroprotectin D1. J Biol Chem 284: 17877-17882.
32. Kimelberg HK, Norenberg MD (1989) Astrocytes. Sci Am 4: 66-72, 74, 76.
33. Tower DB, (1992) A century of neuronal and neurological interactions, and their pathological implications: an overview. Prog Brain Res 94: 3-17.
34. Faghiri Z, Bazan NG, (2010) PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp Eye Res 90: 718-725.
35. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD, et al. (1996) Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture: Neurological and Pathological Evaluation of an Improved Model. Stroke 27: 1616-1623.
36. Thompson SN, Gibson TR, Thompson BM, Deng Y, Hall ED, (2006) Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp Neurol 201: 253-265.